These results suggest that MAGI2-AS3 promotes TNS1 expression by targeting the miR-31-5p/TNS1 axis to inhibit bladder cancer generation, proliferation, migration, and invasion [172]. Here, TNS1 is linked to urinary bladder carcinoma.